A B Kay - Concepedia

Author

A B Kay

Lung Institute ORCID

Also Known As

A B KAY, A B Kay, A Barry Kay, A Kay, A. B. KAY, A. B. Kay, A. Barry Kay, A. Kay, A.B Kay, A.B. KAY

166

Publications

16.9K

Citations

H-Index

Concepts

All Affiliations

Lung Institute Imperial College London Royal Brompton Hospital King's College London

About

A B Kay is an author at Lung Institute specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	52	8.2K
2	Allergy	33	44	7.7K
3	Health Sciences	2	2	44
4	Education	1	1	31
5	Nursing	1	1	31

A B Kay

Publications

14.9K

Citations

H-Index

Page 1

	Year	Citations
Identification of Activated T Lymphocytes and Eosinophils in Bronchial Biopsies in Stable Atopic Asthma May Azzawi, Brian Bradley, Peter K. Jeffery, American Review of Respiratory Disease AsthmaStable Atopic AsthmaFiber Optic BronchoscopyAllergyInflammatory Lung Disease	1990	878
Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics Patrick Flood-Page, Andrew Menzies‐Gow, Simon Phipps, Journal of Clinical Investigation	2003	839
Eosinophil's Role Remains Uncertain as Anti–Interleukin-5 only Partially Depletes Numbers in Asthmatic Airway Patrick Flood-Page, Andrew Menzies‐Gow, A B Kay, American Journal of Respiratory and Critical Care Medicine	2003	804
Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. A B Kay, Sun Ying, Veronica Varney, The Journal of Experimental Medicine Allergy MedicineImmunologyImmune RegulationSkin AllergyAllergen	1991	672
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. Andrew J. Wardlaw, Redwan Moqbel, Oliver Cromwell, Journal of Clinical Investigation Inflammatory MediatorImmunologyPlatelet-activating FactorEosinophilic DisorderInflammation	1986	575
Asthma and inflammation A B Kay Journal of Allergy and Clinical Immunology	1991	568
Eosinophil Chemotactic Chemokines (Eotaxin, Eotaxin-2, RANTES, Monocyte Chemoattractant Protein-3 (MCP-3), and MCP-4), and C-C Chemokine Receptor 3 Expression in Bronchial Biopsies from Atopic and Nonatopic (Intrinsic) Asthmatics Ying Sun, Qiu Meng, Kyriaki Zeibecoglou, The Journal of Immunology AsthmaAllergy MedicineBronchial BiopsiesImmunologyNonatopic Asthma	1999	415
Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ Stephen R. Durham, Ying Sun, Veronica Varney, Journal of Allergy and Clinical Immunology Grass Pollen ImmunotherapyCd4+ TNasal MucosaAllergyAllergy Medicine	1996	414
Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics Marc Humbert, J Barkans, Christopher J. Corrigan, The Journal of Immunology	1997	411
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Marc Humbert, Stephen R. Durham, Sun Ying, American Journal of Respiratory and Critical Care Medicine AsthmaInflammatory Lung DiseaseLung InflammationNonatopic AsthmaImmunology	1996	404

Page 1